Johns Hopkins University Bloomberg School of Public Health

Medications

A perilous prescription: The dangers of unregulated drug ads

During the COVID-19 pandemic, as many stayed home, direct-to-consumer prescription drug advertising—already big business—boomed. Websites, social media, streaming services, and other on-demand platforms became ideal real ...

Diseases, Conditions, Syndromes

A new COVID landscape in China

After three years of implementing its "zero-COVID" strategy, China has dropped all COVID restrictions. In the weeks since, COVID-19 cases, hospitalizations, and deaths have skyrocketed in a country with low immunity and limited ...

Alzheimer's disease & dementia

New study links hearing loss with dementia in older adults

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that older adults with greater severity of hearing loss were more likely to have dementia, but the likelihood of dementia was lower ...

Diseases, Conditions, Syndromes

What you need to know about XBB.1.5, the latest omicron variant

Four weeks ago, the XBB.1.5 variant caused less than 10% of COVID-19 cases in the U.S. Now it causes more than 25% of them. Virologists including Andy Pekosz, a professor of Molecular Microbiology and Immunology, are paying ...

page 5 from 40